Moderna
MRNA
#270
Rank
โ‚น8.689 T
Marketcap
โ‚น21,764
Share price
14.21%
Change (1 day)
814.20%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น281.93 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.21 Billion. In 2025 the company made an earning of -โ‚น266.79 Billion, an increase over its 2024 earnings that were of -โ‚น346.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น281.93 Billion5.68%
2025 -โ‚น266.79 Billion-23.03%
2024 -โ‚น346.59 Billion-8.22%
2023 -โ‚น377.64 Billion-140.65%
2022 โ‚น928.99 B-27.81%
2021 โ‚น1.286 T-1911.15%
2020 -โ‚น71.05 Billion44.7%
2019 -โ‚น49.1 Billion28.63%
2018 -โ‚น38.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.535 T-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.501 T-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น743.85 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.59 Billion-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.39 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น4.04 Billion-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น108.78 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น15.43 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA